These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7363924)

  • 21. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman DC; Dunning AJ
    Postgrad Med J; 1977; 53 Suppl 1():92-6. PubMed ID: 876958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
    Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 27. Simultaneous plasma levels determination of mexiletine and one of its metabolites by electron capture gas-liquid chromatography.
    Pachecus A; Santoni Y; Fornaris M; Magnan S; Aubert C; Ragon A; Cano JP
    Arzneimittelforschung; 1982; 32(6):688-93. PubMed ID: 6889428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of mexiletin on ventricular arrhythmias during ergometric exercise (author's transl)].
    Pozenel H
    Wien Klin Wochenschr; 1977 Dec; 89(23):783-8. PubMed ID: 595602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 30. A modified gas-liquid chromatographic assay to monitor plasma mexiletine in a tinnitus study.
    Pilling M; Tse J; Chan K
    Methods Find Exp Clin Pharmacol; 1982; 4(4):243-7. PubMed ID: 7121133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiarrhythmic treatment with mexiletine in acute myocardial infarction (author's transl)].
    Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A
    G Ital Cardiol; 1981; 11(4):477-80. PubMed ID: 7286520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mexiletine in the treatment of arrhythmia].
    Petelenz T; Chruściel TL; Gaszewska I; Słomińska-Petelenz T; Elertowicz M; Grzybek B
    Pol Tyg Lek; 1982 Aug; 37(29-30):859-62. PubMed ID: 6185933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Side effects after long-term administration of mexiletine].
    Henning B; Merx W; Brunner H; Härtel H
    Verh Dtsch Ges Inn Med; 1978; (84):742-7. PubMed ID: 742114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of kidney, liver or heart insufficiency on blood mexiletine levels].
    Nitsch J; Steinbeck G; Lüderitz B
    Internist (Berl); 1982 May; 23(5):291-3. PubMed ID: 7047453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mexiletine in the treatment of ventricular arrhythmias].
    Tanaka T; Kusumoto M; Miyazawa Y; Umemura J; Suwa J; Komatsu Y
    Kokyu To Junkan; 1986 Mar; 34(3):315-9. PubMed ID: 3704375
    [No Abstract]   [Full Text] [Related]  

  • 40. Mexiletine in clinical practice.
    Boyle DM
    Acta Cardiol Suppl; 1980; (25):137-45. PubMed ID: 6990665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.